Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 6
2007 2
2009 1
2010 2
2011 1
2012 2
2013 1
2014 2
2017 1
2018 2
2019 3
2020 3
2021 3
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib.
Sasaki R, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, Hidaka M, Eguchi S, Matsuo S, Matsuzaki T, Hashimoto S, Ohba K, Kugiyama Y, Yatsuhashi H, Shibata H, Motoyoshi Y, Shigeno M, Iwatsu S, Kato Y, Kinoshita N, Nakao K. Sasaki R, et al. Among authors: motoyoshi y. Anticancer Res. 2021 Apr;41(4):2025-2032. doi: 10.21873/anticanres.14970. Anticancer Res. 2021. PMID: 33813409
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide.
Okamura T, Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T, Yajima H, Miyazaki O, Kuribayashi Y, Ikeda T, Taura N, Nakao K. Okamura T, et al. Among authors: motoyoshi y. Biomed Rep. 2022 Jan;16(1):6. doi: 10.3892/br.2021.1489. Epub 2021 Nov 24. Biomed Rep. 2022. PMID: 34900255 Free PMC article.
Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings.
Sasaki R, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, Hidaka M, Eguchi S, Matsuo S, Tajima K, Matsuzaki T, Hashimoto S, Ooba K, Kugiyama Y, Yatsuhashi H, Motoyoshi Y, Shigeno M, Kinoshita N, Nakao K. Sasaki R, et al. Among authors: motoyoshi y. Cancers (Basel). 2019 Nov 10;11(11):1769. doi: 10.3390/cancers11111769. Cancers (Basel). 2019. PMID: 31717674 Free PMC article.
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease.
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T, Yajima H, Uehara R, Miyazaki O, Kuribayashi Y, Kira K, Taura N, Nakao K. Ichikawa T, et al. Among authors: motoyoshi y. Biomed Rep. 2021 Apr;14(4):34. doi: 10.3892/br.2021.1410. Epub 2021 Feb 11. Biomed Rep. 2021. PMID: 33732453 Free PMC article.
Hepatitis C virus-related symptoms, but not quality of life, were improved by treatment with direct-acting antivirals.
Ichikawa T, Miyaaki H, Miuma S, Taura N, Motoyoshi Y, Akahoshi H, Nakamura S, Nakamura J, Takahashi Y, Honda T, Yajima H, Uehara R, Hino N, Narita S, Tanaka H, Sasaki S, Nakao K. Ichikawa T, et al. Among authors: motoyoshi y. Hepatol Res. 2018 Feb;48(3):E232-E239. doi: 10.1111/hepr.12974. Epub 2017 Nov 13. Hepatol Res. 2018. PMID: 28837746
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease.
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Yamashima M, Yamamichi S, Koike M, Takahashi Y, Honda T, Yajima H, Uehara R, Hino N, Hirata R, Taura N, Nakao K. Ichikawa T, et al. Among authors: motoyoshi y. Biomed Rep. 2020 Mar;12(3):89-98. doi: 10.3892/br.2020.1273. Epub 2020 Jan 24. Biomed Rep. 2020. PMID: 32042417 Free PMC article.
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus.
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi Y, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T, Yajima H, Uehara R, Miyazaki O, Kuribayashi Y, Kira K, Taura N, Nakao K. Ichikawa T, et al. Among authors: motoyoshi y. Intern Med. 2020;59(21):2653-2660. doi: 10.2169/internalmedicine.5102-20. Epub 2020 Nov 1. Intern Med. 2020. PMID: 33132304 Free PMC article.
29 results